Toward improved predictions of pharmacokinetics of transported drugs in hepatic impairment: Insights from the extended clearance model
Abstract Hepatic impairment (HI) moderately (<5‐fold) affects the systemic exposure (i.e., area under the plasma concentration-time curve [AUC]) of drugs that are substrates of the hepatic sinusoidal organic anion transporting polypeptide (OATP) transporters and are excreted unchanged in the bile...
Saved in:
Main Authors: | Flavia Storelli (Author), Mayur K. Ladumor (Author), Xiaomin Liang (Author), Yurong Lai (Author), Paresh P. Chothe (Author), Osatohanmwen J. Enogieru (Author), Raymond Evers (Author), Jashvant D. Unadkat (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predicting changes in the pharmacokinetics of CYP3A‐metabolized drugs in hepatic impairment and insights into factors driving these changes
by: Mayur K. Ladumor, et al.
Published: (2023) -
P-glycoprotein efflux transporter: a key to pharmacokinetic modeling for methadone clearance in fetuses
by: Harvey Ho, et al.
Published: (2023) -
The effect of pregnancy-related hormones on hepatic transporters: studies with premenopausal human hepatocytes
by: Jhohann Richard de Lima Benzi, et al.
Published: (2024) -
Application of Physiologically Based Pharmacokinetic Model to Delineate the Impact of Aging and Renal Impairment on Ceftazidime Clearance
by: Khaled Abduljalil, et al.
Published: (2024) -
Dysregulation of the mRNA Expression of Human Renal Drug Transporters by Proinflammatory Cytokines in Primary Human Proximal Tubular Epithelial Cells
by: Yik Pui Tsang, et al.
Published: (2024)